Literature DB >> 32142919

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.

C Molist1, N Navarro1, I Giralt1, P Zarzosa1, G Gallo-Oller1, G Pons1, A Magdaleno1, L Moreno2, G Guillén3, R Hladun2, M Garrido4, A Soriano1, M F Segura1, J Sánchez de Toledo5, S Gallego6, J Roma7.   

Abstract

The prognosis of patients with metastatic rhabdomyosarcoma (RMS), the most common type of soft tissue sarcoma in children, is poor and no strategies have been identified to improve their dismal prognosis. Alpha-9 integrin (ITGA9) plays a particularly crucial role in cancer progression and invasiveness. Despite the consensus on the remarkable pro-oncogenic potential of this protein, the miRNA-mediated regulation of ITGA9 has barely been studied to date. In the present study, miR-7 and miR-324-5p were selected as the best candidates after a screening to find ITGA9 regulators, and their effects on cell proliferation and invasion in RMS are described and characterized for the first time. Interestingly, the overexpression of both miRNA produced a clear impairment of cell proliferation, while miR-7 also induced a remarkable drop in cell invasion. Furthermore, the stable overexpression of both miRNA was found to reduce tumor growth in orthotopic RMS models and miR-7 was able to impair metastatic lung colonization. Consequently, we conclude that miR-7 and miR-324-5p show anti-oncogenic and anti-metastatic potential, thereby opening up the possibility of being used as novel therapeutic tools to avoid RMS progression.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ITGA9; Integrins; Pediatric cancer; Rhabdomyosarcoma; miRNA

Mesh:

Substances:

Year:  2020        PMID: 32142919     DOI: 10.1016/j.canlet.2020.02.035

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma.

Authors:  Lucia Tombolan; Caterina Millino; Beniamina Pacchioni; Manuela Cattelan; Angelica Zin; Paolo Bonvini; Gianni Bisogno
Journal:  Front Genet       Date:  2020-12-10       Impact factor: 4.599

2.  MicroRNA‑592 promotes cell proliferation, migration and invasion in colorectal cancer by directly targeting SPARC.

Authors:  Zhenguo Pan; Rui Xie; Wei Song; Chengcheng Gao
Journal:  Mol Med Rep       Date:  2021-02-12       Impact factor: 2.952

Review 3.  Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights.

Authors:  Shihan Xu; Tingwei Zhang; Zhengguo Cao; Wenjie Zhong; Chuangwei Zhang; Han Li; Jinlin Song
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

4.  Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.

Authors:  Irina Giralt; Gabriel Gallo-Oller; Natalia Navarro; Patricia Zarzosa; Guillem Pons; Ainara Magdaleno; Miguel F Segura; Constantino Sábado; Raquel Hladun; Diego Arango; José Sánchez de Toledo; Lucas Moreno; Soledad Gallego; Josep Roma
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 6.208

5.  Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration.

Authors:  Zhihao Chen; Liubing Li; Ziyuan Li; Xi Wang; Mingxiao Han; Zongshuai Gao; Min Wang; Gangfeng Hu; Xiaolu Xie; Hong Du; Zonggang Xie; Haifang Zhang
Journal:  Cancer Cell Int       Date:  2022-02-12       Impact factor: 5.722

6.  Structural disruption of BAF chromatin remodeller impairs neuroblastoma metastasis by reverting an invasiveness epigenomic program.

Authors:  Carlos Jiménez; Roberta Antonelli; Mariona Nadal-Ribelles; Laura Devis-Jauregui; Pablo Latorre; Carme Solé; Marc Masanas; Adrià Molero-Valenzuela; Aroa Soriano; Josep Sánchez de Toledo; David Llobet-Navas; Josep Roma; Francesc Posas; Eulàlia de Nadal; Soledad Gallego; Lucas Moreno; Miguel F Segura
Journal:  Mol Cancer       Date:  2022-09-03       Impact factor: 41.444

Review 7.  Non-coding RNA in rhabdomyosarcoma progression and metastasis.

Authors:  Farah Ramadan; Raya Saab; Nader Hussein; Philippe Clézardin; Pascale A Cohen; Sandra E Ghayad
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

8.  Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.

Authors:  Natalia Navarro; Carla Molist; Júlia Sansa-Girona; Patricia Zarzosa; Gabriel Gallo-Oller; Guillem Pons; Ainara Magdaleno; Gabriela Guillén; Raquel Hladun; Marta Garrido; Miguel F Segura; Lourdes Hontecillas-Prieto; Enrique de Álava; Berta Ponsati; Jimena Fernández-Carneado; Ana Almazán-Moga; Mariona Vallès-Miret; Josep Farrera-Sinfreu; Josep Sánchez de Toledo; Lucas Moreno; Soledad Gallego; Josep Roma
Journal:  Cell Mol Life Sci       Date:  2022-10-11       Impact factor: 9.207

9.  Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p.

Authors:  Jinglin Li; Canghai Guan; Zengtao Hu; Lang Liu; Zhilei Su; Pengcheng Kang; Xingming Jiang; Yunfu Cui
Journal:  Hum Cell       Date:  2020-10-10       Impact factor: 4.174

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.